Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Prospective, Randomized, Controlled, Assessor-Blinded Study Evaluating the Efficacy and Safety of the Antiseptic Ophthalmic Solution Piclosept in the Complex Treatment of Neonatal Dacryocystitis

NCT07875517 is registered in ClinicalTrials.gov with Kazakh Eye Research Institute as lead sponsor.

NCT NCT07875517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07875517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Prospective, Randomized, Controlled, Assessor-Blinded Study Evaluating the Efficacy and Safety of the Antiseptic Ophthalmic Solution Piclosept in the Complex Treatment of Neonatal Dacryocystitis
Lead sponsor
Kazakh Eye Research Institute
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 25, 2026
Completion date
November 20, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital nasolacrimal duct obstruction, neonatal dacryocystitis